• الرئیسیة
  • البحث المتقدم
  • قائمة المکتبات
  • حول الموقع
  • اتصل بنا
  • نشأة
  • ورود / ثبت نام

عنوان
Accelerating the development of biomarkers for drug safety :

پدید آورنده
Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

موضوع
Biochemical markers, Congresses.,Drugs-- Safety measures, Congresses.,Drugs-- Testing, Congresses.,Biological Markers, Congresses.,Drug Design, Congresses.,Drug Discovery, Congresses.,Drug Toxicity, Congresses.,Pharmaceutical Preparations-- adverse effects, Congresses.,Biochemical markers.,Drugs-- Safety measures.,Drugs-- Testing.,MEDICAL-- Diagnosis.,MEDICAL-- Laboratory Medicine.,MEDICAL-- Nursing-- Assessment & Diagnosis.

رده
R853
.
B54
A23
2009eb

کتابخانه
کتابخانه مطالعات اسلامی به زبان های اروپایی

محل استقرار
استان: قم ـ شهر: قم

کتابخانه مطالعات اسلامی به زبان های اروپایی

تماس با کتابخانه : 32910706-025

0309131243
0309131251
1282272659
6612272651
9780309131247
9780309131254
9781282272651
9786612272653
9780309131247

b775583

Accelerating the development of biomarkers for drug safety :
[Book]
workshop summary /
Steve Olson, Sally Robinson and Robert Giffin, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.

Washington, D.C. :
National Academies Press,
©2009.

1 online resource (xiv, 84 pages) :
illustrations

Includes bibliographical references.

Introduction -- Overview Of key issues -- Cardiac safety biomarkers -- Assessing and predicting kidney safety -- Biomarkers of acute idiosyncratic hepatocellular injury in clinical trials -- Future considerations.
0

"Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has risen in recent years, reducing the number of new drugs approved for use, biomarker development may be a way to cut costs, enhance safety, and provide a more focused and rational pathway to drug development. On October 24, 2008, the IOM's Forum on Drug Discovery, Development, and Translation held "Assessing and Accelerating Development of Biomarkers for Drug Safety," a one-day workshop, summarized in this volume, on the value of biomarkers in helping to determine drug safety during development."

Accelerating the development of biomarkers for drug safety.
9780309131247

Biochemical markers, Congresses.
Drugs-- Safety measures, Congresses.
Drugs-- Testing, Congresses.
Biological Markers, Congresses.
Drug Design, Congresses.
Drug Discovery, Congresses.
Drug Toxicity, Congresses.
Pharmaceutical Preparations-- adverse effects, Congresses.
Biochemical markers.
Drugs-- Safety measures.
Drugs-- Testing.
MEDICAL-- Diagnosis.
MEDICAL-- Laboratory Medicine.
MEDICAL-- Nursing-- Assessment & Diagnosis.

K
MED-- 018000
MED-- 047000
MED-- 058020

616
.
075
22

R853
.
B54
A23
2009eb

2009
K-807
QV
744
I59c
2009

Giffin, Robert B.
Olson, Steve,1956-
Robinson, Sally.

Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation.

20201203081046.0
pn

 مطالعه متن کتاب 

[Book]

Y

الاقتراح / اعلان الخلل

تحذیر! دقق في تسجیل المعلومات
ارسال عودة
تتم إدارة هذا الموقع عبر مؤسسة دار الحديث العلمية - الثقافية ومركز البحوث الكمبيوترية للعلوم الإسلامية (نور)
المكتبات هي المسؤولة عن صحة المعلومات كما أن الحقوق المعنوية للمعلومات متعلقة بها
برترین جستجوگر - پنجمین جشنواره رسانه های دیجیتال